Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
48
VRNS Quote, Financials, Valuation and Earnings
Last price:
$42.83
Seasonality move
:
8.93%
Day range:
$42.15 - $43.02
52-week range:
$36.53 - $60.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.68x
P/B ratio:
10.58x
Volume:
854.1K
Avg. volume:
1.4M
1-year change:
-4.61%
Market cap:
$4.8B
Revenue:
$551M
EPS (TTM):
-$0.86
Analysts' Opinion
-
Consensus RatingVaronis Systems has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $51.21, Varonis Systems has an estimated upside of 19.6% from its current price of $42.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $39.00 representing 8.92% downside risk from its current price of $42.82.
Fair Value
-
According to the consensus of 17 analysts, Varonis Systems has 19.6% upside to fair value with a price target of $51.21 per share.
VRNS vs. S&P 500
-
Over the past 5 trading days, Varonis Systems has overperformed the S&P 500 by 4.67% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Varonis Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Varonis Systems has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Varonis Systems reported revenues of $158.5M.
Earnings Growth
-
Varonis Systems has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Varonis Systems reported earnings per share of -$0.12.
Enterprise value:
5B
EV / Invested capital:
--
Price / LTM sales:
8.68x
EV / EBIT:
--
EV / Revenue:
8.99x
PEG ratio (5yr expected):
--
EV / Free cash flow:
48.62x
Price / Operating cash flow:
46.94x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$457.1M
Return On Assets:
-7.44%
Net Income Margin (TTM):
-17.38%
Return On Equity:
-20.96%
Return On Invested Capital:
-10.79%
Operating Margin:
-11.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $473.6M | $499.2M | $551M | $154.1M | $158.5M | |
| Gross Profit | $403.8M | $427.4M | $457.1M | $134.8M | $132.5M | |
| Operating Income | -$121.2M | -$117.2M | -$117.7M | -$5.2M | -$17.6M | |
| EBITDA | -$95.5M | -$72M | -$67.3M | $31.2M | $24.2M | |
| Diluted EPS | -$1.14 | -$0.92 | -$0.86 | -$0.01 | -$0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $419.8M | $959.2M | $905.7M | $767.2M | $878.1M | |
| Total Assets | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
| Current Liabilities | $182.6M | $211.8M | $228.7M | $306.8M | $709.9M | |
| Total Liabilities | $461.4M | $511.9M | $541.6M | $614.3M | $1.2B | |
| Total Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
| Total Debt | $218.5M | $225.3M | $249M | $250.5M | $700.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $11.9M | $59.4M | $115.2M | $10.4M | $24.3M | |
| Cash From Investing | -$374.3M | -$143.1M | -$532.3M | $110.4M | -$119.4M | |
| Cash From Financing | -$75.6M | -$53.4M | $371.9M | -$1.3M | -$1.5M | |
| Free Cash Flow | $475K | $54.3M | $101.9M | $8.3M | $19.9M | |
VRNS
Sector
Market Cap
$4.8B
$78.3M
Price % of 52-Week High
70.68%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
-1.8%
0.76%
1-Year Price Total Return
-4.61%
-18.18%
Beta (5-Year)
0.757
0.870
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$41.30
200-day SMA
Sell
Level
$48.55
Bollinger Bands (100)
Sell
Level
40.67 - 46.45
Chaikin Money Flow
Buy
Level
82.8M
20-day SMA
Buy
Level
$40.78
Relative Strength Index (RSI14)
Buy
Level
59.55
ADX Line
Buy
Level
10.44
Williams %R
Sell
Level
-3.3642
50-day SMA
Buy
Level
$41.42
MACD (12, 26)
Buy
Level
0.21
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
124.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1566)
Sell
CA Score
(Annual)
Level (-1.2925)
Buy
Beneish M-Score
(Annual)
Level (-3.1174)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.0399)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.
Stock Forecast FAQ
In the current month, VRNS has received 10 Buy ratings 7 Hold ratings, and 0 Sell ratings. The VRNS average analyst price target in the past 3 months is $51.21.
-
Where Will Varonis Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Varonis Systems share price will rise to $51.21 per share over the next 12 months.
-
What Do Analysts Say About Varonis Systems?
Analysts are divided on their view about Varonis Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Varonis Systems is a Sell and believe this share price will drop from its current level to $39.00.
-
What Is Varonis Systems's Price Target?
The price target for Varonis Systems over the next 1-year time period is forecast to be $51.21 according to 17 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is VRNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Varonis Systems is a Buy. 10 of 17 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VRNS?
You can purchase shares of Varonis Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Varonis Systems shares.
-
What Is The Varonis Systems Share Price Today?
Varonis Systems was last trading at $42.83 per share. This represents the most recent stock quote for Varonis Systems. Yesterday, Varonis Systems closed at $42.82 per share.
-
How To Buy Varonis Systems Stock Online?
In order to purchase Varonis Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
